Thermo Fisher Scientific Expects 2020 Revenue to Grow 20%
October 21 2020 - 10:43AM
Dow Jones News
By Dave Sebastian
Thermo Fisher Scientific Inc. executives said the company
expects 2020 revenue to grow 20% to about $30.52 billion, its first
full-year outlook since it withdrew guidance in April due to
Covid-19 uncertainty.
The scientific-equipment and diagnostics company also expects
adjusted earnings to rise 48% to $18.27 a share for the year,
executives said on a conference call Wednesday.
The estimates are higher than the outlook it put out in late
January, when it guided for adjusted earnings of $13.49 to $13.67 a
share on revenue of $26.61 billion to $27.01 billion.
The company on Wednesday posted higher-than-expected profit and
sales for the September quarter as it benefited from demand for
Covid-19 testing.
For the fourth quarter, the company expects organic growth of
29%, with an expected $1.75 billion in Covid-19 response revenue
and organic growth in the base business of low- to mid-single
digits, Finance Chief Stephen Williamson said.
The company expects fourth-quarter adjusted earnings to grow
about 60% from the same quarter last year, Mr. Williamson said. He
added that the outlook doesn't anticipate the kind of lockdowns
seen earlier this year amid the pandemic.
Shares rose 2.4% to $476.50.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
October 21, 2020 10:28 ET (14:28 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024